NRT REGULATION
Medical device regulation is an ever-changing global landscape. Our focus on regulatory engagement in emerging nicotine replacement therapy (NRT) product standards ensures that we’re best informed when developing products.
QUALITY
Quality is on our DNA and we take our responsibilities seriously. We’re proud to be certified by the British Standards Institution (BSI) to the international standards ISO14001, ISO9001 and ISO13485 for your complete confidence.
NRT R&D
In order to make sure that our NRT inhaler products are developed and innovated in-line with the best possible working practices, we conduct all of our work in strict adherence with research and development standards.
NRT specialists
Ventus Medical is a pharmaceutical company specialising in the innovation of novel inhalation technologies. We bring together the expertise needed in create, develop and protect nicotine replacement therapy products that have the potential to benefit public health.
Our NRT innovations
The first of our innovations has recently received approval as a medical device in the European Union. Our carefully developed NRT inhaler, ENHALE, has been designed to help adult smokers to quit smoking by alleviating nicotine withdrawal symptoms.
Our Mission
At Ventus Medical, our mission is simple – to contribute to a world without the harm and suffering caused by tobacco consumption. Our mission is to develop safer and more effective nicotine replacement therapy solutions to help smokers eliminate the harm caused to them by smoking.
- Integrity
- Diversity
- Collaboration
- Sustainability
- Ingenuity
- Excellence
The Ventus vision
We want to create innovative NRT inhaler solutions to help the world’s smokers, one breath at a time.